The role of Mcl-1 in the response of human colorectal cancer cells to treatment with dichloroacetate
Dichloroacetate (DCA) it a metabolic reprogramming agent that is used to target the unique metabolism of cancer cells, but is not always effective in colorectal cancer cells. In HCT116 cells, DCA was unable to induce apoptosis, but did decrease proliferation when compared to untreated cells. A decre...
Main Author: | Delaney, Leanne |
---|---|
Other Authors: | Coomber, Brenda |
Language: | en |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10214/7418 |
Similar Items
-
The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis
by: Hojatolla Nikravesh, et al.
Published: (2021-08-01) -
Targeting MCL-1 in cancer: current status and perspectives
by: Haolan Wang, et al.
Published: (2021-04-01) -
Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas
by: Kristina M. Cook, et al.
Published: (2021-07-01) -
The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
by: Stefanie Klenke, et al.
Published: (2019-03-01) -
Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer
by: Natalie Yan Li Ngoi, et al.
Published: (2020-03-01)